search for



Crossref

Cross mark

Cited-by

Fundref

TDM

CrossRef (0)
Relationship between Smoking Duration and Metabolic Syndrome in Korean Former Smokers
J Korean Soc Res Nicotine Tob 2018; 9(1): 18-25
Published online June 15, 2018
© 2018 The Korean Society for Research on Nicotine and Tobacco.

Ji Ae Youn1, Yong Hwan Lee2*, Myoung Sook Noh1

1Department of Family Medicine, Busan Samyook Hospital, Busan, 2Department of Preventive Medicine, Kosein University College of Medicine, Busan, Korea
Correspondence to: 씠슜솚
怨좎떊븰援 쓽怨쇰븰 삁諛⑹쓽븰援먯떎 遺궛떆 꽌援 媛먯쿇濡 262 (슦)49267
Tel: 051-990-6402 Fax: 051-248-9826 E-mail: dragon36515@gmail.com
Received February 8, 2018; Revised April 17, 2018; Accepted May 30, 2018.
 Abstract
Background: Despite several studies on the association between metabolic syndrome (MS) and smoking duration in current smokers, it has not been completely clarified in former smokers. This study aimed to assess the relationship between smoking duration and MS in Korean former smokers. Methods: This study was a cross-sectional study using data from 1,792 former smokers aged 19 years and older of the sixth (2014-2015) Korean National Health and Nutritional Examination Surveys. Former smokers were categorized into three groups, 竊10 years, 돟10 years and 竊20 years, and 돟20 years according to past smoking duration. The odds ratios (ORs) and 95% confidence intervals (CIs) for MS and its components were estimated using multiple logistic regression models. Results: In male subjects, compared with the former smokers who smoked for less than 10 years, the OR of MS was 1.82 (95% CI: 1.10-3.01) in former smokers who smoked for more than 20 years. The ORs of hyperglycemia and high triglyceride were 1.68 (95% CI: 1.04-2.71) and 1.99 (95% CI: 1.14-3.47), respectively, in former male smokers who smoked for more than 20 years, with adjustment for age, household income and educational level, alcohol drinking, aerobic exercise, current health status, daily smoking amount, and smoking cessation duration. Conclusion: These data suggest that male former smokers who smoked for more than 20 years may have high risks of MS, hyperglycemia, and high triglyceride, even though smoking was quitted.
Keywords : Former Smokers; Smoking Duration; Metabolic Syndrome
References
  1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595-607.
    Pubmed CrossRef
  2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365: 1415-28.
    CrossRef
  3. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28: 1769-78.
    Pubmed CrossRef
  4. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3): 391-7.
    Pubmed CrossRef
  5. Ponciano-Rodriguez G, Paez-Martinez N, Villa-Romero A, GutierrezGrobe Y, Mendez-Sanchez N. Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation. Metab Syndr Relat Disord. 2014; 12: 242-50.
    Pubmed CrossRef
  6. Facchinin FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992; 339: 1128-30.
    CrossRef
  7. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002; 16; 106:286-8.
    CrossRef
  8. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S et al. Association between cigarette smoking and metabolic syndrome: The Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005; 28: 2064-6.
    CrossRef
  9. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med. 2007; 46:1167-70.
    Pubmed CrossRef
  10. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005; 43: 295-301.
    Pubmed CrossRef
  11. Oh JE. Association between smoking status and metabolic syndrome in men. Korean J Obes. 2014; 23: 99-105.
    CrossRef
  12. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism. 2008; 57: 544-8.
    Pubmed CrossRef
  13. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007; 46:1079-82
    Pubmed CrossRef
  14. Filozof C, Fern찼ndez Pinilla MC, Fern찼ndez-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004; 5: 95-103.
    Pubmed CrossRef
  15. Korea Centers for Disease Control and Prevention. The 6th Korea National Health and Nutrition Examination Survey (KNHANES VI) [Internet]. Ministry of Health and Welfare. [cited 2017 Aug 31].
  16. Kang JH, Song YM. Association between cotinine-verified smoking status and metabolic syndrome: analyses of Korean National Health and Nutrition Examination Surveys 2008-2010. Metab Syndr Relat Disord. 2015; 13: 140-8.
    Pubmed CrossRef
  17. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007; 75: 72-80.
    Pubmed CrossRef
  18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52.
    Pubmed CrossRef
  19. Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism. 2004; 53: 863-7.
    Pubmed CrossRef
  20. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29-33.
    Pubmed CrossRef
  21. Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol. 2010; 25: 393-402.
    Pubmed CrossRef
  22. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007; 298: 2654-64.
    Pubmed CrossRef
  23. Kim BJ, Han JM, Kang JG, Rhee EJ, Kim BS, Kang JH. Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults. J Clin Lipidol 2017; 11: 638-45.
    Pubmed CrossRef
  24. Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord. 2001; 25: 1225-32.
    Pubmed CrossRef
  25. Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens. 2007; 20: 637-41.
    Pubmed CrossRef
  26. Benowitz NL, Sharp DS. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation. 1989; 80: 1309-12.
    CrossRef
  27. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999; 33: 586-90.
    Pubmed CrossRef